Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.38 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.25 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.25 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
11.92 | 17620307 19061943 17162532 16434500 18056438 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.92 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.29 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.42 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.97 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.80 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.80 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.80 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.09 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.87 | 16681979 18506893 20101231 20524982 10737359 19171122 16698587 3581430 20432363 19052882 20512989 17138121 18665156 20727157 19418558 19539802 19208518 16328049 16935385 17978847 17162532 18393292 18494052 20084675 20214788 16288022 18978308 17173139 16540662 21159647 19919837 3084413 19383236 19519916 18056438 20514400 16569478 20935162 18971187 20007298 16830150 16878318 18691550 19701751 19107877 19822196 18210153 19394651 17428255 18788625 10672840 16807293 11831363 17761372 19335982 16779866 16502159 17055752 18785209 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.54 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.40 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.40 | 21159647 7505956 17174075 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
10.43 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
10.43 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.17 | 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.24 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.22 | 8697196 12621046 16354765 15340226 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 10048152 20055451 15322242 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.10 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.45 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.45 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.72 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.72 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.72 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.02 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.74 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.51 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.37 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.73 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.98 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.98 | 21071580 20387270 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.94 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.14 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.14 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.21 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.99 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.99 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.71 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.37 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.66 | 16959395 15340226 16354765 18606429 8697196 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.31 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.31 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.44 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.44 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.49 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 18776723 8314463 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.99 | 20032147 19638242 18522880 18665156 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.16 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
8.02 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
8.02 | 19426721 20434301 12771043 20101389 19812893 20118626 19690152 15885732 20137499 19850985 19427195 19090486 12112319 18648771 18754104 19551842 20492335 21071580 18644402 21167192 21047994 18977376 9163691 18978307 19073162 20501860 19499222 19996281 20405173 19254457 10737359 15175105 19638242 19642983 20452335 2422723 19833225 2862719 19294768 19255062 19256749 20583210 16942905 21278145 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
8.02 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.45 | 17854601 18544905 16842330 18253720 18308698 18164116 2563599 18079962 18282651 18093689 19519916 16267830 9362446 18775883 17174075 19539802 19004024 17942915 21159647 19009564 3124819 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.45 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.52 | 18520028 18569708 20135361 20064080 20464547 18816296 17053015 6695378 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.52 | 20970405 6695378 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.52 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.46 | 14737004 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.31 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.68 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.31 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.65 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.65 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.73 | 20387270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.52 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.86 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.00 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
10.05 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
10.05 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.73 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.15 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.28 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.95 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.95 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.40 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.40 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.25 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.29 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.21 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.86 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |